MXPA03000837A - Pharmaceutical composition containing citalopram. - Google Patents

Pharmaceutical composition containing citalopram.

Info

Publication number
MXPA03000837A
MXPA03000837A MXPA03000837A MXPA03000837A MXPA03000837A MX PA03000837 A MXPA03000837 A MX PA03000837A MX PA03000837 A MXPA03000837 A MX PA03000837A MX PA03000837 A MXPA03000837 A MX PA03000837A MX PA03000837 A MXPA03000837 A MX PA03000837A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
composition containing
containing citalopram
citalopram
pharmaceutical
Prior art date
Application number
MXPA03000837A
Other languages
Spanish (es)
Inventor
Ole Nielsen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA03000837(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MXPA03000837A publication Critical patent/MXPA03000837A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
MXPA03000837A 2000-08-10 2001-07-30 Pharmaceutical composition containing citalopram. MXPA03000837A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27
PCT/DK2001/000520 WO2001080619A2 (en) 2000-08-10 2001-07-30 Pharmaceutical composition containing citalopram

Publications (1)

Publication Number Publication Date
MXPA03000837A true MXPA03000837A (en) 2003-06-06

Family

ID=26068858

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03000837A MXPA03000837A (en) 2000-08-10 2001-07-30 Pharmaceutical composition containing citalopram.

Country Status (34)

Country Link
EP (1) EP1318805A2 (en)
JP (1) JP2003531153A (en)
KR (1) KR20030024833A (en)
CN (1) CN1446089A (en)
AR (1) AR030095A1 (en)
AT (1) AT5744U1 (en)
AU (2) AU2001100198B4 (en)
BE (1) BE1013559A6 (en)
BG (1) BG107578A (en)
BR (1) BR0113250A (en)
CA (1) CA2353693C (en)
CH (2) CH694241A5 (en)
CZ (1) CZ2003397A3 (en)
DE (2) DE20113195U1 (en)
EA (1) EA200300247A1 (en)
ES (1) ES2172481B2 (en)
FI (1) FI5176U1 (en)
FR (1) FR2812811B1 (en)
GB (1) GB2368014B (en)
GR (1) GR1004193B (en)
HR (1) HRP20030054A2 (en)
HU (1) HUP0103071A3 (en)
IE (1) IES20010693A2 (en)
IL (1) IL154050A0 (en)
IS (1) IS6021A (en)
IT (1) ITMI20011637A1 (en)
MX (1) MXPA03000837A (en)
NL (1) NL1018741C1 (en)
NO (1) NO20013891L (en)
NZ (1) NZ523785A (en)
PL (1) PL359824A1 (en)
SK (1) SK2842003A3 (en)
WO (1) WO2001080619A2 (en)
YU (1) YU9003A (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
ATE388947T1 (en) * 2002-12-23 2008-03-15 Lundbeck & Co As H ESCITALOPRAM HYDROBROMIDE AND A METHOD FOR THE PRODUCTION THEREOF
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (en) * 2006-01-05 2007-12-12 昆明积大制药有限公司 Antidepressant composition containing citalopram and cyclodextrin
GB2480191A (en) * 2007-02-02 2011-11-09 Ubiquisys Ltd Determining the location of a base station
WO2017020841A1 (en) * 2015-08-03 2017-02-09 深圳信立泰药业股份有限公司 Pharmaceutical composition containing lcz696 and preparation method thereof
WO2022153262A1 (en) * 2021-01-18 2022-07-21 Anton Frenkel Pharmaceutical dosage form

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug response by a serotonin 1A receptor antagonist
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram

Also Published As

Publication number Publication date
NO20013891L (en) 2002-02-11
YU9003A (en) 2006-05-25
IES20010693A2 (en) 2002-07-10
NO20013891D0 (en) 2001-08-09
AT5744U1 (en) 2002-11-25
CZ2003397A3 (en) 2003-06-18
JP2003531153A (en) 2003-10-21
CA2353693C (en) 2003-07-22
FR2812811B1 (en) 2006-08-18
BG107578A (en) 2003-09-30
ES2172481B2 (en) 2004-08-01
CH694241A5 (en) 2004-10-15
NZ523785A (en) 2004-09-24
HU0103071D0 (en) 2001-10-28
IL154050A0 (en) 2003-07-31
AU2001279591A1 (en) 2001-11-07
DE10139115A1 (en) 2002-03-28
GB2368014A (en) 2002-04-24
ITMI20011637A0 (en) 2001-07-27
SK2842003A3 (en) 2003-09-11
WO2001080619A2 (en) 2001-11-01
AR030095A1 (en) 2003-08-13
CN1446089A (en) 2003-10-01
GR20010100377A (en) 2002-09-06
AU2001100198B4 (en) 2002-06-13
ITMI20011637A1 (en) 2003-01-27
CA2353693A1 (en) 2002-01-22
WO2001080619A3 (en) 2002-02-21
HUP0103071A3 (en) 2002-12-28
IS6021A (en) 2001-10-20
FR2812811A1 (en) 2002-02-15
BR0113250A (en) 2003-06-24
ES2172481A1 (en) 2002-09-16
FI5176U1 (en) 2001-12-27
BE1013559A6 (en) 2002-03-05
EA200300247A1 (en) 2003-06-26
HRP20030054A2 (en) 2005-02-28
GR1004193B (en) 2003-03-24
GB2368014B (en) 2004-06-23
HUP0103071A2 (en) 2002-05-29
GB0118579D0 (en) 2001-09-19
KR20030024833A (en) 2003-03-26
EP1318805A2 (en) 2003-06-18
AU2001100198A4 (en) 2001-08-16
NL1018741C1 (en) 2002-02-12
CH694242A5 (en) 2004-10-15
DE20113195U1 (en) 2001-11-15
PL359824A1 (en) 2004-09-06

Similar Documents

Publication Publication Date Title
MXPA03000771A (en) New pharmaceutical composition.
ZA200003998B (en) Pharmaceutical compositions.
HK1045650A1 (en) Pharmaceutical composition.
IL152659A0 (en) Pharmaceutical composition
HK1075889A1 (en) Pharmaceutical composition
HUP0204555A3 (en) Pharmaceutical composition
ZA200203486B (en) Novel pharmaceutical compositions.
ZA200210359B (en) Pharmaceutical compositions.
ZA200005510B (en) Pharmaceutical composition.
ZA200000857B (en) Pharmaceutical composition.
MXPA03000837A (en) Pharmaceutical composition containing citalopram.
MXPA03002105A (en) Pharmaceutical compositions.
HK1044117A1 (en) Pharmaceutical composition.
MXPA01000464A (en) Composition.
MXPA03005965A (en) Pharmaceutical composition containing citalopram.
ZA200110500B (en) Pharmaceutical composition.
GB0005382D0 (en) Pharmaceutical composition
MXPA03007318A (en) Pharmaceutical composition.
ZA200110501B (en) Pharmaceutical composition.
ZA997202B (en) Pharmaceutical composition.
ZA200110499B (en) Pharmaceutical composition.
GB0002691D0 (en) Pharmaceutical composition
GB0101094D0 (en) Pharmaceutical composition
GB0219820D0 (en) Pharmaceutical compostion containing citalopram
ZA200303911B (en) Medicinal compositions.